ATE258229T1 - Substanz fa-70d, herstellungsverfahren und verwendungen - Google Patents

Substanz fa-70d, herstellungsverfahren und verwendungen

Info

Publication number
ATE258229T1
ATE258229T1 AT97904590T AT97904590T ATE258229T1 AT E258229 T1 ATE258229 T1 AT E258229T1 AT 97904590 T AT97904590 T AT 97904590T AT 97904590 T AT97904590 T AT 97904590T AT E258229 T1 ATE258229 T1 AT E258229T1
Authority
AT
Austria
Prior art keywords
compound
substance
production methods
drug
osteoporosis
Prior art date
Application number
AT97904590T
Other languages
English (en)
Inventor
Shizuo Kitano
Toru Sasaki
Kenichiro Yoshida
Toshio Otani
Lei Yu
Yun Wu
Nobuhiko Katsunuma
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE258229T1 publication Critical patent/ATE258229T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97904590T 1996-02-21 1997-02-20 Substanz fa-70d, herstellungsverfahren und verwendungen ATE258229T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3352396 1996-02-21
PCT/JP1997/000472 WO1997031122A1 (en) 1996-02-21 1997-02-20 Substance fa-70d, process for producing the same, and uses thereof

Publications (1)

Publication Number Publication Date
ATE258229T1 true ATE258229T1 (de) 2004-02-15

Family

ID=12388910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97904590T ATE258229T1 (de) 1996-02-21 1997-02-20 Substanz fa-70d, herstellungsverfahren und verwendungen

Country Status (9)

Country Link
US (1) US5914348A (de)
EP (1) EP0822260B1 (de)
JP (1) JP3111240B2 (de)
KR (1) KR100271997B1 (de)
AT (1) ATE258229T1 (de)
AU (1) AU695190B2 (de)
CA (1) CA2217729C (de)
DE (1) DE69727268T2 (de)
WO (1) WO1997031122A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420396B1 (en) 1998-12-16 2002-07-16 Beiersdorf Ag Biphenyl and biphenyl-analogous compounds as integrin antagonists
US6677360B2 (en) 1998-12-16 2004-01-13 Bayer Aktiengesellschaft Biphenyl and biphenyl-analogous compounds as integrin antagonists
KR20020042333A (ko) * 2000-11-30 2002-06-05 이계준 프로테아제 억제 활성을 갖는 약학적 조성물
AU2003277644A1 (en) * 2002-11-29 2004-06-23 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
NZ536338A (en) * 2002-11-29 2006-04-28 Morinaga Milk Industry Co Ltd Lactoferrin as a cysteine protease inhibitor
CN116396359A (zh) * 2020-02-17 2023-07-07 中国医学科学院医药生物技术研究所 一组具有抗病毒活性的肽类化合物奥米克欣a族化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667995B2 (en) * 1993-02-15 1996-04-18 Bayer Aktiengesellschaft New pseudopeptides having an antiviral action
JPH07123995A (ja) * 1993-11-04 1995-05-16 Yamanouchi Pharmaceut Co Ltd トリペプチド化合物
JPH083188A (ja) * 1994-06-15 1996-01-09 Sankyo Co Ltd 新規化合物キモスタチノール類及びその製法
JPH08151394A (ja) * 1994-11-25 1996-06-11 Yamanouchi Pharmaceut Co Ltd ジペプチド化合物

Also Published As

Publication number Publication date
JP3111240B2 (ja) 2000-11-20
DE69727268D1 (de) 2004-02-26
EP0822260A1 (de) 1998-02-04
EP0822260B1 (de) 2004-01-21
CA2217729C (en) 2001-04-10
KR100271997B1 (ko) 2000-11-15
DE69727268T2 (de) 2004-12-16
CA2217729A1 (en) 1997-08-28
AU1734097A (en) 1997-09-10
AU695190B2 (en) 1998-08-06
EP0822260A4 (de) 2000-05-31
US5914348A (en) 1999-06-22
WO1997031122A1 (en) 1997-08-28
KR19990007955A (ko) 1999-01-25

Similar Documents

Publication Publication Date Title
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
NO941937L (no) Sakarinderivater som inhiberer proteolytiske enzymer
TR199800849T2 (xx) Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
NO950297D0 (no) Prolinamidderivater
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
GEP19991871B (en) Thiol Derivatives with Metallopeptidase Inhibitory Activity
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
EP0342587A3 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE258229T1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
DK1123937T3 (da) Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf
HUT77135A (hu) Eljárás I típusú allergiás betegségek megelőzésére és kezelésére alkalmazható gyógyszerkészítmények előállítására
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
SE9700244D0 (sv) Novel antibacterial protein
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
EP0721985A4 (de) Die substanz it-62-b und sie enthaltende medizinische zubereitungen
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties